[
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN118R",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 118,
      "aas": "R"
    },
    "comment": "G118R is an uncommon nonpolymorphtic HIV-2-associated drug-resistance mutation which reduces susceptibility to multiple INSTIs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN121Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 121,
      "aas": "Y"
    },
    "comment": "F121Y is an uncommon nonpolymorphic HIV-1-associated drug-resistance mutation which has not yet been reported in HIV-2 infected patients."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN140SAC",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 140,
      "aas": "SAC"
    },
    "comment": "G140S/A are common nonpolymorphic HIV-2 associated drug-resistance mutation that usually occur in combination with Q148 mutations."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN143CRGH",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 143,
      "aas": "CRGH"
    },
    "comment": "Y143C/R/G/H are non-polymorphic HIV-2-associated drug-resistance mutations which reduce susceptibility to RAL. In combination with other mutations, they may also reduce susceptibility to EVG."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN147G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 147,
      "aas": "G"
    },
    "comment": "S147G is a non-polymorphic HIV-1-associated drug-resistance mutation that has also been reported in INSTI-experienced persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN148HKR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 148,
      "aas": "HKR"
    },
    "comment": "Q148H/K/R are nonpolymorphic HIV-2 associated drug-resistance mutations, which reduce susceptibilit to each of the INSTIs. Q148R and Q148K are associated with greater levels of reduced susceptibility than Q148H. G140 mutations contribute to reduced susceptibility."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN153G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 153,
      "aas": "G"
    },
    "comment": "A153G is a nonpolymorphic HIV-2 mutation that is selected by INSTIs usually in combination with N155H."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN155H",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 155,
      "aas": "H"
    },
    "comment": "N155H is a nonpolymorphic HIV-2 associated drug-resistance mutation which redu es susceptibility to RAL and EVG. It contributes reduced susceptibility to DTG and probably BIC in combination with other drug-resistance mutations."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN231_",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 231,
      "aas": "_"
    },
    "comment": "Among HIV-2 isolates, amino acid insertions at position 231 are selected by INSTIs and associated with markedly reduced INSTI susceptibility."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN263K",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 263,
      "aas": "K"
    },
    "comment": "R263K is a nonpolymorphic HIV-2-associated drug-resistance mutation which has so far been rarely reported in HIV-2 infected persons. It reduces susceptibility to DTG, BIC, and probably also to EVG and RAL."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN51Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 51,
      "aas": "Y"
    },
    "comment": "H51Y is an uncommon HIV-1-associated drug-resistance mutation which has not yet been reported in INSTI-treated HIV-2 infected persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN66AIK",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 66,
      "aas": "AIK"
    },
    "comment": "T66AIK are HIV-1-associated drug-resistance mutation which have not yet been reported in HIV-2 infected patients."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN84V",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 84,
      "aas": "V"
    },
    "comment": "I84V is a polymorphic HIV-2 associated mutation that occurs significantly more commonly in INSTI-experienced compared with INSTI-na\u00efve persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN91R",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 91,
      "aas": "R"
    },
    "comment": "Q91R is a nonpolymorphic HIV-2 associated mutation that occurs significantly more commonly in INSTI-experienced compared with INSTI-na\u00efve persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN92GQ",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 92,
      "aas": "GQ"
    },
    "comment": "E92Q/G are nonpolymorphic HIV-2 associated drug resistance mutations that reduce susceptibility to RAL and EVG. They may contribute to reduced DTG and BIC susceptibility in combination with other drug-resistance mutations."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN97A",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 97,
      "aas": "A"
    },
    "comment": "T97A is a common nonpolymorphic common INSTI-selected mutation. In combination with other DRMs, it contributes reduced susceptibility to RAL, EVG, and possibly DTG and BIC."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR10I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 10,
      "aas": "I"
    },
    "comment": "V10I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR23I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 23,
      "aas": "I"
    },
    "comment": "L23I is an uncommon non-polymorphic HIV-1 associated PI-resistance mutation that has not been reported in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR30N",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 30,
      "aas": "N"
    },
    "comment": "D30N is a non-polymorphic mutation that causes high-level HIV-1 resistance to NFV. It has rarely been reported in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR33I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 33,
      "aas": "I"
    },
    "comment": "V33I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR45R",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 45,
      "aas": "R"
    },
    "comment": "K45R is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR47A",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 47,
      "aas": "A"
    },
    "comment": "V47A is a common non-polymorphic PI-selected HIV-2 mutation that reduces HIV-2 susceptibility to LPV and other PIs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR48VA",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 48,
      "aas": "VA"
    },
    "comment": "G48VA are non-polymorphic PI-selected HIV-2 mutations."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR50L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 50,
      "aas": "L"
    },
    "comment": "I50L is a non-polymorphic HIV-2 mutation selected by ATV. It causes high-level resistance to ATV and increases susceptibility to most of the remaining PIs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR50V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 50,
      "aas": "V"
    },
    "comment": "I50V is a non-polymorphic PI-selected mutation that reduces HIV-2 susceptibility to LPV and other PIs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR53LY",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 53,
      "aas": "LY"
    },
    "comment": "F53LY are nonpolymorphic mutations that have rarely been reported in treated HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR54L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 54,
      "aas": "L"
    },
    "comment": "I54L is a nonpolymorphic PI-selected mutation."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR54M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 54,
      "aas": "M"
    },
    "comment": "I54M is a very common non-polymorphic PI-selected mutation. It is associated with reduced HIV-2 susceptibility to multiple Pis."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR56V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 56,
      "aas": "V"
    },
    "comment": "T56V is a common nonpolymrophic mutation that occurs significantly more commonly in HIV-2 isolates from PI-treated vs. PI-na\u00efve isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR62A",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 62,
      "aas": "A"
    },
    "comment": "V62A is a nonpolymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates. It has been selected in vitro by IDV and been shown to contribute reduced suscptibility to LPV in combination with other DRMs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR64V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 64,
      "aas": "V"
    },
    "comment": "I64V is a polymorphic mutation that occurs singnificatnly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR71I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 71,
      "aas": "I"
    },
    "comment": "V71I is a common polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR73G",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 73,
      "aas": "G"
    },
    "comment": "A73G is a nonpolymorphic mutation that occurs significantly more commonoly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR82F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 82,
      "aas": "F"
    },
    "comment": "I82F is a common non-polymorphic PI-selected HIV-2 mutation that reduces HIV-2 susceptibility to LPV and other PIs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR82LM",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 82,
      "aas": "LM"
    },
    "comment": "I82LM are nonpolymorphic PI-selected HIV-2 mutations."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR84V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 84,
      "aas": "V"
    },
    "comment": "I84V is a non-polymorphic PI-selected HIV-2 mutation associated with reduced susceptibility to multiple Pis."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR85L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 85,
      "aas": "L"
    },
    "comment": "F85L is a non-polymorphic PI-selected HIV-2 mutation."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR88D",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 88,
      "aas": "D"
    },
    "comment": "N88D is a nonpolymorphic HIV-1-associated PI resistance mutation that has rarely been reported in HIV-2 isolatea."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR90M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 90,
      "aas": "M"
    },
    "comment": "L90M is a non-polymorphic PI-selected HIV-2 mutation."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR99F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 99,
      "aas": "F"
    },
    "comment": "L99F is a polymorphic HIV-2 mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve persons. It has been selected in vitro by IDV and been shown to contribute reduced suscptibility to LPV in combination with other DRMs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART111I",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 111,
      "aas": "I"
    },
    "comment": "V111I is a common polymorphic mutation that occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons. It appears to increase the replication fitness of HIV-2 strains containing other HIV-2-associated NRTI-resistance mutations."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART115F",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 115,
      "aas": "F"
    },
    "comment": "Y115F is an HIV-1-associated NRTI-resistance mutation that also reduces HIV-2 susceptibility to each of the NRTIs when it occurs in combination with K65R."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART116Y",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 116,
      "aas": "Y"
    },
    "comment": "F116Y is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART151M",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 151,
      "aas": "M"
    },
    "comment": "Q151M causes high-level resistance to each of the NRTIs except possibly TXF."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART184VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 184,
      "aas": "VI"
    },
    "comment": "M184V/I cause high-level in vitro resistance to XTC and low-level resistance to ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to TXF and are associated with clinically significant reductions in HIV-1 replication."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART210ACDEFGHIKLMPQRSTVWY_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 210,
      "aas": "ACDEFGHIKLMPQRSTVWY_-"
    },
    "comment": "210W is an HIV-1 associated TAM. The HIV-2 consensus at this position is N. Mutations at this position have not been selected by NRTIs in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART214L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 214,
      "aas": "L"
    },
    "comment": "F214L is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART215YF",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 215,
      "aas": "YF"
    },
    "comment": "S215Y/F occur significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but their effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART219ACDFGHIKLMNPQRSTVWY_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 219,
      "aas": "ACDFGHIKLMNPQRSTVWY_-"
    },
    "comment": "219QENR are HIV-1 associated TAMs. The HIV-2 consensus at this position is E. K219D has been observed in several NRTI-treated HIV-2-infected persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART40R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 40,
      "aas": "R"
    },
    "comment": "K40R is a nonpolymorphic mutation that occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons. It usually occurs in combination with S215YF mutations. Its effect on HIV-2 NRTI susceptibility is not known."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART41L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 41,
      "aas": "L"
    },
    "comment": "M41L is an HIV-1 associated TAM that has not been reported in NRTI-treated HIV-2-infected persons and has not been associated with reduced HIV-2 NRTI susceptibility."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART62V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 62,
      "aas": "V"
    },
    "comment": "A62V is a nonpolymoprhic HIV-1 associated mutation that also occurs significantly more commonly in HIV-2 sequences from NRTI-treated persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART65EN",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 65,
      "aas": "EN"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons and is associated with reduced susceptibility to each of the NRTIs except possibly AZT. K65N/E are mutations that have rarely been selected by TDF, ABC, and d4T in HIV-1 isolates and have not been reported in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART65R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 65,
      "aas": "R"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons and is associated with reduced susceptibility to each of the NRTIs except possibly AZT."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART67NGESTH",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 67,
      "aas": "NGESTH"
    },
    "comment": "D67 mutations are commonly occurring HIV-1-assocated TAMs that are rarely selected in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART69-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 69,
      "aas": "-"
    },
    "comment": "Deletions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but have not been reported in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART69S",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 69,
      "aas": "S"
    },
    "comment": "N69S is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons. Its effect on HIV-2 NRTI susceptibility is not known."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART69_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 69,
      "aas": "_"
    },
    "comment": "Insertions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but have not been reported in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART70N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 70,
      "aas": "N"
    },
    "comment": "K70N is a nonpolymorphic HIV-1 associated mutation, which is selected by TDF and ABC. It has been reported in HIV-2 sequences but its effect on HIV-2 NRTI susceptibility is not known."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART70R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 70,
      "aas": "R"
    },
    "comment": "K70R is a nonpolymorphic HIV-1 associated mutations. It occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but its effects on HIV-2 susceptibility to NRTIs is not known."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART74VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 74,
      "aas": "VI"
    },
    "comment": "L74VI are common HIV-1-associated NRTI-resistance mutations that have rarely been reported in HIV-2 sequences."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART75V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 75,
      "aas": "V"
    },
    "comment": "I75V occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART77L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 77,
      "aas": "L"
    },
    "comment": "F77L is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  }
]